Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Is a |
Co-magaldrox product (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antacid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Aluminium |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has manufactured dose form |
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Is a |
Product containing aluminium hydroxide and magnesium hydroxide (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Laxative |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Aluminium hydroxide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium-based antacid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium hydroxide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Trace element supplementation |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has manufactured dose form |
Conventional release oral tablet (dose form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Magnesium hydroxide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has basis of strength substance (attribute) |
Magnesium hydroxide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength numerator value |
300 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Aluminium hydroxide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has basis of strength substance (attribute) |
Aluminium hydroxide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength numerator value |
600 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength denominator unit (attribute) |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has basis of strength substance (attribute) |
Aluminium hydroxide |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength numerator value |
600 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has basis of strength substance (attribute) |
Magnesium hydroxide |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength numerator value |
300 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has precise active ingredient |
Magnesium hydroxide |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has unit of presentation |
Tablet (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has precise active ingredient |
Aluminium hydroxide |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Is a |
Product containing aluminium hydroxide and magnesium hydroxide in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Plays role |
Laxative therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Is a |
Aluminium hydroxide and magnesium hydroxide only product in oral dose form |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|